Escitalopram vs Lebrikizumab

## Escitalopram vs Lebrikizumab: Overview

This comparison examines the pharmacological differences between **Escitalopram** and **Lebrikizumab**.

## Mechanism of Action

**Escitalopram**: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

## Pharmacokinetics

**Half-life**: Escitalopram — 27-32 hours; Lebrikizumab — N/A.

## Chemical Properties

**Molecular Formula**: Escitalopram — C20H21FN2O; Lebrikizumab — N/A.

**Molecular Weight**: Escitalopram — 324.3920 g/mol; Lebrikizumab — N/A.

**Type**: Escitalopram — Small molecule; Lebrikizumab — Antibody.